Na Su

782 total citations
46 papers, 505 citations indexed

About

Na Su is a scholar working on Endocrinology, Diabetes and Metabolism, Surgery and Molecular Biology. According to data from OpenAlex, Na Su has authored 46 papers receiving a total of 505 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Endocrinology, Diabetes and Metabolism, 10 papers in Surgery and 10 papers in Molecular Biology. Recurrent topics in Na Su's work include Diabetes Treatment and Management (9 papers), Lipoproteins and Cardiovascular Health (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Na Su is often cited by papers focused on Diabetes Treatment and Management (9 papers), Lipoproteins and Cardiovascular Health (4 papers) and Chronic Lymphocytic Leukemia Research (3 papers). Na Su collaborates with scholars based in China, United States and Norway. Na Su's co-authors include Sheyu Li, Shengzhao Zhang, Hanrui Zheng, Qingyang Shi, Yuzhen Tong, Yi Li, Nanwei Tong, Haoming Tian, Lizhi Tang and Li Huang and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cochrane Database of Systematic Reviews and Journal of Medicinal Chemistry.

In The Last Decade

Na Su

42 papers receiving 500 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Na Su China 14 139 135 120 71 63 46 505
Ye Won Jeon South Korea 14 143 1.0× 105 0.8× 123 1.0× 46 0.6× 48 0.8× 36 566
Yi‐Chih Lin Taiwan 7 119 0.9× 140 1.0× 77 0.6× 35 0.5× 64 1.0× 16 483
Michael J. Knauer Canada 12 94 0.7× 56 0.4× 126 1.1× 47 0.7× 47 0.7× 25 603
Tomohiro Mizuno Japan 16 150 1.1× 77 0.6× 161 1.3× 52 0.7× 51 0.8× 69 772
Shanyan Lin China 16 198 1.4× 138 1.0× 107 0.9× 45 0.6× 73 1.2× 40 814
Peter D. Montan United States 11 103 0.7× 163 1.2× 197 1.6× 24 0.3× 75 1.2× 14 492
M. Dominique Ashen United States 13 147 1.1× 156 1.2× 138 1.1× 43 0.6× 68 1.1× 23 628
Márcia Martins Silveira Bernik Brazil 14 112 0.8× 78 0.6× 215 1.8× 23 0.3× 113 1.8× 22 551
Hernan Rincon-Choles United States 11 154 1.1× 111 0.8× 95 0.8× 35 0.5× 62 1.0× 22 625
Pang H Chong United States 11 100 0.7× 107 0.8× 290 2.4× 32 0.5× 40 0.6× 22 583

Countries citing papers authored by Na Su

Since Specialization
Citations

This map shows the geographic impact of Na Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Na Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Na Su more than expected).

Fields of papers citing papers by Na Su

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Na Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Na Su. The network helps show where Na Su may publish in the future.

Co-authorship network of co-authors of Na Su

This figure shows the co-authorship network connecting the top 25 collaborators of Na Su. A scholar is included among the top collaborators of Na Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Na Su. Na Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Dong, Xiaoyu, Yu Zou, Na Su, et al.. (2025). Novel 2D/3D vascular biomarkers reveal association between fundus changes and coronary heart disease. Microvascular Research. 159. 104793–104793.
3.
Wang, Ting, Na Su, Wenjuan Liu, et al.. (2025). L-Phenylalanine preharvest spraying effectively enhances the reactive oxygen metabolism and antioxidant capacity in postharvest broccoli. Plant Physiology and Biochemistry. 227. 110185–110185. 2 indexed citations
4.
Yang, Shiwen, et al.. (2025). Serum uric acid reduction through SGLT2 inhibitors: evidence from a systematic review and meta-analysis. Frontiers in Pharmacology. 16. 1551390–1551390.
5.
Su, Na, Abdullah Al Mamun, Mohammad Nurul Hassan Reza, Qing Yang, & Muhammad Mehedi Masud. (2024). Unveiling the nexus between quality and student engagement in web-based collaborative learning systems. Education and Information Technologies. 29(17). 23717–23752. 4 indexed citations
6.
Zheng, Hanrui, Jiafeng Li, Feng Wen, & Na Su. (2023). Cost-effectiveness of analysis serplulimab plus chemotherapy as first-line therapy for PD-L1-positive advanced esophageal squamous cell carcinoma. Frontiers in Oncology. 13. 1216960–1216960. 1 indexed citations
7.
Wang, Hui, Jianglin Zhao, Chufeng Wang, et al.. (2023). Cardiovascular safety of Janus kinase inhibitors in patients with rheumatoid arthritis: systematic review and network meta-analysis. Frontiers in Pharmacology. 14. 1237234–1237234. 13 indexed citations
8.
Xie, Qian, et al.. (2022). Camrelizumab in patients with advanced non-squamous non-small cell lung cancer: a cost-effective analysis in China. BMJ Open. 12(8). e061592–e061592. 3 indexed citations
9.
Su, Na, Ting Xu, Xiaodan Li, et al.. (2022). Heparin and Related Substances for Treating Diabetic Foot Ulcers: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 13. 749368–749368. 1 indexed citations
10.
Cao, Qiang, Na Su, Wanhu Li, et al.. (2022). Response Prediction to Concurrent Chemoradiotherapy in Esophageal Squamous Cell Carcinoma Using Delta-Radiomics Based on Sequential Whole-Tumor ADC Map. Frontiers in Oncology. 12. 787489–787489. 6 indexed citations
11.
Zheng, Hanrui, Min Liu, Sheyu Li, et al.. (2021). Sodium-Glucose Co-Transporter-2 Inhibitors in Non-Diabetic Adults With Overweight or Obesity: A Systematic Review and Meta-Analysis. Frontiers in Endocrinology. 12. 706914–706914. 39 indexed citations
12.
Zhang, Shengzhao, Ting Xu, Qingyang Shi, et al.. (2021). Cardiovascular Safety of Febuxostat and Allopurinol in Hyperuricemic Patients With or Without Gout: A Network Meta-Analysis. Frontiers in Medicine. 8. 698437–698437. 16 indexed citations
13.
Liu, Chang, Siqi Tang, Kang An, et al.. (2021). Knowledge, Attitude, and Practice of Metformin Extended-Release Tablets Among Clinicians in China: A Cross-Sectional Survey. Frontiers in Pharmacology. 12. 634561–634561. 4 indexed citations
14.
Liu, Ying, et al.. (2020). Literature Analysis of the Efficacy of Arbidol in Virus Infectious Diseases. Biointerface Research in Applied Chemistry. 11(1). 7646–7658. 2 indexed citations
15.
Wang, Wen, Yanmei Liu, Chuan Yu, et al.. (2020). Cefoperazone-sulbactam and risk of coagulation disorders or bleeding: a retrospective cohort study. Expert Opinion on Drug Safety. 19(3). 339–347. 35 indexed citations
16.
17.
Su, Na, Yun Li, Ting Xu, et al.. (2016). Exenatide in obese or overweight patients without diabetes: A systematic review and meta-analyses of randomized controlled trials. International Journal of Cardiology. 219. 293–300. 18 indexed citations
18.
Su, Na, et al.. (2010). Efficacy and Safety of Wenxin Granules in the Treatment of Congestive Heart Failure: A Systematic Review. Zhongguo yaofang. 4 indexed citations
19.
Wang, Gang, et al.. (2006). Study on pharmacokinetics of methotrexate in children's acute lymphocytic leukemia. Chinese Journal of Hospital Pharmacy. 1 indexed citations
20.
Wang, Xiaolin, Guanxin Shen, Bei Sun, & Na Su. (1989). Studies on lymphocyte subpopulations and NK cell activities in epileptic patients. Journal of Tongji Medical University. 9(1). 25–28. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ye Won Jeon Breakdown of academic impact, for papers by Yi‐Chih Lin Breakdown of academic impact, for papers by Michael J. Knauer Breakdown of academic impact, for papers by Tomohiro Mizuno Breakdown of academic impact, for papers by Shanyan Lin Breakdown of academic impact, for papers by Peter D. Montan Breakdown of academic impact, for papers by M. Dominique Ashen Breakdown of academic impact, for papers by Márcia Martins Silveira Bernik Breakdown of academic impact, for papers by Hernan Rincon-Choles Breakdown of academic impact, for papers by Pang H Chong
Rankless by CCL
2026